Unilever is looking to sell or de-emphasize its food & beverage units as it eyes the consumer healthcare division of GlaxoSmithKline, whose products include Advil pain reliever and Aquafresh and Sensodyne toothpaste.
The latest bid was reported at $68 billion, which would require Unilever to raise cash, which may prompt it to sell off its remaining food & beverage portfolio.
Unilever’s food & beverage products include Ben & Jerry’s ice cream and Hellman’s mayonnaise.
According to Unilever, its strategic direction lies in materially expanding its health, beauty, and hygiene businesses, which would require major acquisitions accompanied by the accelerated divestment of lower-growth brands and businesses.
Unilever had sold parts of its food and beverage businesses recently, including its spreads portfolio in 2017 and most of its tea business in 2020.
According to Unilever CEO Alan Jope, while its food and refreshments products are still profitable, its long-term growth profile has been below other parts of its portfolio.


Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Washington Post Publisher Will Lewis Steps Down After Layoffs
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Thailand Inflation Remains Negative for 10th Straight Month in January
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off 



